RFK Jr. Reportedly Plans 10,000 Job Cuts in HHS With FDA, CDC, Medicare Affected

Seeking AlphaMar 27 08:22 ET

Sanofi's Chief Digital Officer Says Remote Work Means Employees Lose the 'Serendipity' Needed to Innovate

Yahoo FinanceMar 27 02:00 ET

Top Gap Ups and Downs on Wednesday: SAP, ASML, SONY and More

Moomoo NewsMar 26 18:00 ET · Markets

FDA Fast Tracks Sanofi's MRNA Vaccine for Chlamydia

Yahoo FinanceMar 26 08:15 ET

Marty Makary and Jay Bhattacharya Clear Senate Hurdles to Lead FDA and NIH

Seeking AlphaMar 26 06:56 ET

Sanofi Hits 4-week Low

Trading EconomicsMar 26 04:00 ET

Sanofi Gets US FDA Fast Track Designation for Chlamydia Vaccine Candidate

MT NewswiresMar 26 02:10 ET

Press Release: Chlamydia Vaccine Candidate Granted Fast Track Designation by the US FDA

SanofiMar 26 00:00 ET

J.P. Morgan Sticks to Its Hold Rating for Sanofi (SNYNF)

TipRanksMar 25 04:05 ET · Ratings

Sanofi's Tolebrutinib Granted FDA Priority Review For Non-Relapsing Secondary Progressive MS, Targeting Smoldering Neuroinflammation

BenzingaMar 25 02:24 ET

Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Sanofi (OtherSNYNF) and MacroGenics (MGNX)

TipRanksMar 24 20:50 ET · Ratings

Press Release: Availability of the Q1 2025 Aide Mémoire

SanofiMar 24 00:00 ET

Notable Healthcare Headlines for the Week: Pfizer, Sanofi, Sarepta Therapeutics and Medtronic in Focus

Seeking AlphaMar 23 09:05 ET

Sanofi Initiated at Neutral at Goldman Sachs on Need to See Pipeline Successes

Seeking AlphaMar 21 13:31 ET

This Is What Needs to Happen for Sanofi Shares to Rally in 2025: Goldman Sachs

InvestingMar 21 09:24 ET

This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

BenzingaMar 21 09:11 ET

Goldman Sachs Initiates Sanofi(SNY.US) With Hold Rating, Announces Target Price $65

Moomoo NewsMar 21 07:31 ET · Ratings

CDC Vaccine Meeting, Delayed Under RFK Jr., Is Rescheduled

Seeking AlphaMar 21 07:21 ET

Banks Launch €7.45 Billion Debt Sale for Sanofi Unit Buyout

Yahoo FinanceMar 21 05:28 ET

Goldman Sachs Initiates Coverage On Sanofi With Neutral Rating, Announces Price Target of $65

BenzingaMar 21 05:22 ET · Ratings